Literature DB >> 19040337

The pharmacological treatment of depression in adults with epilepsy.

Marco Mula1, Bettina Schmitz, Josemir W Sander.   

Abstract

BACKGROUND: Comorbid mood disorders may affect quality of life in people with epilepsy.
OBJECTIVE: To review available data on the use of antidepressant drugs in epilepsy taking into account major concerns that may be encountered by clinicians, namely pharmacokinetic interactions with antiepileptic medications and seizure aggravation.
RESULTS: Data on pharmacotherapy of depression in epilepsy are limited with no controlled clinical trials investigating efficacy and safety of antidepressants. Data on seizure risk come from psychiatric samples, thus limiting the general applicability to people with epilepsy.
CONCLUSIONS: Antidepressant drug doses need to be used and adjusted according to individual clinical needs. Within the therapeutic range, the incidence of seizures in psychiatric populations is low for most antidepressants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19040337     DOI: 10.1517/14656560802587024

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  9 in total

1.  Depression in epilepsy: mechanisms and therapeutic approach.

Authors:  Marco Mula; Bettina Schmitz
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

Review 2.  Depression in epilepsy: a critical review from a clinical perspective.

Authors:  Christian Hoppe; Christian E Elger
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

Review 3.  Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps.

Authors:  Eric M Wassermann; Trelawny Zimmermann
Journal:  Pharmacol Ther       Date:  2011-09-07       Impact factor: 12.310

Review 4.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

5.  A Trial of Sertraline or Cognitive Behavior Therapy for Depression in Epilepsy.

Authors:  Frank G Gilliam; Kevin J Black; Jewell Carter; Kenneth E Freedland; Yvette I Sheline; Wei-Yann Tsai; Patrick J Lustman
Journal:  Ann Neurol       Date:  2019-08-15       Impact factor: 10.422

Review 6.  Epilepsy and Psychiatric Comorbidities: Drug Selection.

Authors:  Marco Mula
Journal:  Curr Treat Options Neurol       Date:  2017-10-19       Impact factor: 3.598

Review 7.  Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2).

Authors:  Amos D Korczyn; Steven C Schachter; Martin J Brodie; Sarang S Dalal; Jerome Engel; Alla Guekht; Hrvoje Hecimovic; Karim Jerbi; Andres M Kanner; Cecilie Johannessen Landmark; Pavel Mares; Petr Marusic; Stefano Meletti; Marco Mula; Philip N Patsalos; Markus Reuber; Philippe Ryvlin; Klára Štillová; Roberto Tuchman; Ivan Rektor
Journal:  Epilepsy Behav       Date:  2013-06-10       Impact factor: 2.937

8.  Depressive disorders in patients with pharmaco-resistant mesial temporal lobe epilepsy.

Authors:  Eleonora Borges Gonçalves; Tania Aparecida Marchiori de Oliveira Cardoso; Clarissa Lin Yasuda; Fernando Cendes
Journal:  J Int Med Res       Date:  2017-09-27       Impact factor: 1.671

9.  Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations.

Authors:  C S Garcia
Journal:  Epilepsy Res Treat       Date:  2011-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.